PRE-MARKET | November 14, 2016 | $AAPL, $KO, $TWTR, $HAR, $X, #TRUMP, #IPHONE7, #traders , $TF_F, $NQ_F

by Alpha | Nov 14, 2016 | Pre-Market

PRE-MARKET MOVERS

1. CRBP:

$CRBP Corbus’s lead drug succeeds in mid-stage scleroderma study – Rueters

2. HAR:

$HAR Samsung to Buy U.S. Auto-Parts Supplier Harman for $8 Billion – WSJ

3. EBIO:

$EBIO Eleven Biotherapeutics Swings to Q3 Profit – Street Insider

4. BDC, DGII:

$DGII Digi Rejects $13.82/shr Proposal From Belden $BDC – Quick Facts – RTT

5. MENT:

$MENT Siemens to Buy U.S. Software Maker Mentor for $4.5 Billion – BBG

6. AYA:

$AYA Amaya gets $3.48B offer from former CEO David Baazov – BNN

7. OCUL:

$OCUL Ocular Therapeutix™ Announces Successful Topline Results for Ph 3 Clinical Trial of DEXTENZA™

8. SCLN:

$SCLN Gl Management submit proposal to buyout the Co at $11.18 per share in cash – Reuters

9. TWTR:

$TWTR Twitter Attracts an Activist Investor – Street Insider

10. KATE:

$KATE Kate Spade Receives Letter from Caerus Investors; Recommends Exploring Potential Sale – SI

11. CTL, LVLT:

$CTL Level 3–CenturyLink Merger Looks Smart $LVLT – Barron’s

12. BUD, KO:

$KO Budweiser $BUD and Coca-Cola: a match brewed in heaven – The Telegraph

13. SRPT: $SRPT EU Decision for Translarna Has Positive Read Through for Sarepta – Credit Suisse

14. DIS, NFLX: $NFLX Is Netflix Disney’s $DIS next big buy and is Reed Hastings its next CEO? – TechCrunch

15. GIL: $GIL Gildan Activewear Announces Proposed Acquisition of American Apparel Brand – MarketWired

16. NVS:

$NVS Novartis Said to Hold Talks to Buy Generics Maker Amneal – BBG

17. DVAX:

$DVAX Dynavax says FDA rejects its hepatitis B vaccine – Reuters

UPGRADES

1. ATU:Baird Upgrades Actuant $ATU to Outperform

2. CFX:Argus Upgrades Colfax Corporation $CFX to Buy

3. CHS:Chico’s FAS was Upgraded to a Buy Rating at Wolfe Research $CHS

4. CS:BofA/Merrill Lynch Upgrades Credit Suisse $CS to Buy

5. KSS:Citi Upgrades Kohl’s $KSS to Buy

6. LB:Citi Upgrades L Brands $LB to Buy

7. LMT:$LMT upgraded to Buy at Stifel Nicolaus – PT raise $290 from $260

8. LSXMA:Macquarie Upgrades Liberty SiriusXM $LSXMA to Outperform

9. NRG:UPDATE: UBS Upgrades NRG Energy $NRG to Neutral

10. PF:UPDATE: UBS Upgrades Pinnacle Foods $PF to Buy

11. PLCE:BofA/Merrill Lynch Upgrades The Children’s Place $PLCE to Buy

12. PTCT:Credit Suisse Upgrades PTC Therapeutics $PTCT to Outperform; ROW Translarna Sales Risk Off the …

13. SQ:Square catches upgrade at Pacific Crest

14. X:$X upgraded to Overweight at Morgan Stanley – PT raise $46 from $19

DOWNGRADES

1. C, SEAS:Citigroup Downgrades SeaWorld to Hold $SEAS $C

2. CFG:Sandler O’Neill Downgrades Citizens Financial Group $CFG to Hold

3. CLGX:Piper Jaffray Downgrades CoreLogic $CLGX to Neutral

4. ELY:Compass Point Downgrades Callaway Golf $ELY to Neutral

5. ESPR:Citi Downgrades Esperion Therapeutics $ESPR to Neutral

6. HEAR:B. Riley Downgrades Turtle Beach Corporation $HEAR to Neutral

7. NUE:Berenberg Downgrades Nucor $NUE to Hold Citing Valuation after Sharp Rally

8. RARE:Citi Downgrades Ultragenyx Pharma $RARE to Sell

9. USB:U.S. Bancorp downgraded at Morgan Stanley

10. VIAB:Brean Capital Downgrades Viacom $VIAB to Hold; Merger with CBS Does Not Maximize Value

11. VLY:Sandler O’Neill Downgrades Valley National Bancorp $VLY to Hold

12. WBS:Wells Fargo Downgrades Webster Financial $WBS to Market Perform

13. WERN:Deutsche Bank Downgrades Werner Enterprises $WERN to Hold

14. WSM:Robert W. Baird Downgrades Williams-Sonoma to Hold $WSM

EARNINGS

1. PN:$PN reports FQ3 earnings of 12c EPS and $60.22M Revs –

2. ACM:$ACM reports FQ4 earnings of 65c EPS and $4.32B Revs –

3. STNG:$STNG reports FQ3 earnings of -11c EPS and $114.34M Revs –

4. CRNT:$CRNT reports FQ3 earnings of 6c EPS and $79.13M Revs –

5. TDG:$TDG reports FQ4 earnings of $3.29 EPS and $875.22M Revs –

6. AXAS:$AXAS reports FQ3 earnings of -2c EPS and $13.98M Revs –

7. AXAS:$AXAS reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $1.13M –

Trending Social Alerts

1. DVAX:$DVAX CRL

2. NVDA:$NVDA upgraded to BUY at Needham, price tgt goes to $100

3. PTCT:$PTCT upgraded to Outperform at Credit Suisse, PT $25

4. CRBP:$CRBP Reports Positive Topline Results Showing Clear Signal of Clinical Benefit with Resunab in Phase 2 Study in Systemic Sclerosis

Trending News Headlines

1. Twitter (TWTR) Attracts an Activist Investor

Twitter (NYSE: TWTR) is gaining following a…

2. Dynavax shares fall on FDA rejection of hepatitis b vaccine

Dynavax now says it will need assistance from another drug company or financial partner to resubmit Heplisav-B for another shot at approval.

3. Novartis Said to Hold Talks to Buy Generics Maker Amneal

Novartis AG is in talks to acquire U.S. generic-drugs maker Amneal Pharmaceuticals LLC as the Swiss health-care company seeks to bolster its Sandoz business amid consolidation in the industry, according to people familiar with the matter.

4. Corbus drug succeeds in mid-stage scleroderma study, shares surge

Corbus Pharmaceuticals Holdings Inc said its only drug outperformed a placebo in a mid-stage study involving patients with a form of systemic sclerosis, an incurable autoimmune condition caused by abnormal growth of connective tissue.

5. Corbus Pharmaceuticals Reports Positive Topline Results Showing Clear Signal of Clinical Benefit with Resunab (JBT-101) in Phase 2 Study in Systemic Sclerosis

Corbus Pharmaceuticals Holdings, Inc. , a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced positive topline results from its …

6. UPDATE: Stifel Starts Gilead Sciences (GILD) at Buy

(Updated – November 14, 2016 9:10 AM EST) Stifel initiated coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $100.Analyst Katherine…

7. CME Said to Consider Dublin for Clearing Amid Brexit Fallout

CME Group Inc. is examining options in Dublin to ensure its clearinghouse keeps access to European Union customers after the U.K. leaves the bloc, according to people familiar with the discussions.

8. Goldman Sees the Possibility of Stagflation Under Trump Presidency

Higher inflation and unemployment.

9. Samsung to Buy U.S. Auto-Parts Supplier Harman for $8 Billion

Samsung said it would buy U.S. auto-parts supplier Harman International Industries for $8 billion in an all-cash deal that instantly makes the South Korean smartphone maker a major player in the world of automotive technology.

Technology News

1. Zuckerberg says he will have more to share soon on updates to address fake news, says FB has to tread carefully

2. Issue isn’t did Facebook impact election. Underlying question is whether it has responsibility to block known lies

3. I talked to Y Combinator and @torbahax about the Trump-related social media harassment that got him kicked out of YC

4. Facebook sacked staff who worked on ‘trending topics’ because of bias, but now its algorithms can’t filter fake news

5. This from Facebook is absolute chickenshit.

6. Facebook is embroiled in accusations that it helped spread fake news stories that influenced how Americans voted.

7. AFF hacked, 103m passwords were stored in plain text, 232m SHA1’ed – 99.3% now cracked –

8. Funny how alt-right idiots mock minority fear, yet can’t handle any discomfort themselves:

9. The extortion economy is strong, but lets not call them “researchers”:

10. As expected, battery life on the low end 13” is measurably better than the touch bar models.

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This

Share this post with your friends!